Test Price
2,800 AED✅ Home Collection Available
MATN3 Gene Spondyloepimetaphyseal Dysplasia Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MATN3 لخلل التنسج الفقاري المشاشي الكردوسي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | ملخص تنفيذي
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Clinical Overview & Diagnostic Positioning
The MATN3 Gene Spondyloepimetaphyseal Dysplasia Genetic Test is a definitive molecular diagnostic assay designed to detect pathogenic variants in the MATN3 gene associated with autosomal dominant spondyloepimetaphyseal dysplasia. يكتشف هذا الاختبار الجيني الطفرات المسببة للأمراض في جين MATN3 المرتبط بخلل التنسج الفقاري المشاشي الكردوسي. It utilizes Next Generation Sequencing (NGS) for comprehensive coding region coverage, making it the gold standard over single-gene Sanger sequencing for identifying both known and novel variants.
| Feature | Our Test (NGS - UAE) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | >99.9% for Target Region | ~99% per amplicon |
| Methodology | NGS (Next Generation Sequencing) with Copy Number Analysis | Sanger Sequencing only |
| Speed (TAT) | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocol
From Dr. PRABHAKAR REDDY (DHA: 61713011): "Interpreting MATN3 results requires correlating genotype with skeletal radiographs. A negative NGS panel does not exclude all skeletal dysplasias, and variants of uncertain significance must be evaluated in the context of family history. I emphasize that this test is most powerful when combined with a thorough physical exam and pedigree analysis."
"من الضروري الربط بين الطفرات الجينية والأشعة الهيكلية لتشخيص دقيق. النتيجة السلبية لا تنفي الإصابة، ويجب تقييم الطفرات غير المعروفة بدقة." - الدكتور برابهاكار ريدي
⚠️ MEDICATION WARNING: Do not discontinue prescribed medication without consulting your doctor. Genetic testing is a diagnostic tool, not a substitute for ongoing clinical management or therapeutic intervention.
🛑 Safety Box: Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients unable to provide informed consent; infants under 28 days (heel-prick protocol not applicable for whole blood draw); acute hemolytic anemia requiring immediate intervention.
- ER Red Flags: If you experience sudden hearing loss, severe joint pain with fever, or acute vision changes, seek emergency care immediately. These symptoms are not related to the blood draw but may indicate progression of skeletal dysplasia complications.
- Sample Collection Contraindications: Do not proceed with collection if the patient is on high-dose anticoagulants (INR >3.5) or has active cellulitis at the venipuncture site.
Patient FAQ & Clinical Guidance
Q: What does the MATN3 NGS test detect, and what does a positive result mean for my child's skeletal development?
A: This test identifies pathogenic mutations in the MATN3 gene causing spondyloepimetaphyseal dysplasia, directly confirming the genetic cause of short stature, spinal abnormalities, and early-onset osteoarthritis. A positive result guides orthopedic surveillance and physical therapy protocols for preserving joint function and mitigating degenerative changes.
ج: يكشف هذا الاختبار الطفرات الجينية المسببة لخلل التنسج الفقاري المشاشي الكردوسي، مما يؤكد السبب الوراثي لقصر القامة وتشوهات العمود الفقري والتهاب المفاصل المبكر. النتيجة الإيجابية توجه المراقبة العظمية والعلاج الطبيعي للحفاظ على وظيفة المفاصل.
Q: Why choose this specific NGS test in the UAE over a whole exome sequencing (WES)?
A: A targeted MATN3 NGS panel provides 100% read depth for the gene of interest leading to higher diagnostic yield for this specific phenotype, avoids incidental findings unrelated to skeletal dysplasia, and costs 60% less than whole exome sequencing. This focused approach complies with DHA guidelines for phenotype-driven genetic testing, ensuring rapid results.
ج: يوفر اختبار NGS الموجه لجين MATN3 عمق قراءة بنسبة 100% للجين المستهدف، مما يزيد من الدقة التشخيصية لهذا الاضطراب، ويتجنب النتائج العرضية غير المرتبطة بخلل التنسج، ويكلف أقل بنسبة 60% من تسلسل الإكسوم الكامل.
Q: How is my DNA sample collected, stored, and protected under UAE privacy law?
A: DNA is extracted from a simple blood draw or FTA card, transported at 2-8°C under an ISO-certified cold chain, and de-identified prior to sequencing in strict compliance with UAE PDPL—your genetic data is never shared without explicit written consent.
ج: يتم استخراج الحمض النووي من عينة دم بسيطة أو بطاقة FTA، ونقلها بسلسلة تبريد معتمدة حسب ISO، وإخفاء هويتها قبل التسلسل الجيني وفقاً لقانون حماية البيانات الشخصية الإماراتي—لا تتم مشاركة بياناتك الجينية دون موافقة خطية صريحة.
UAE Regulatory Compliance: This service strictly adheres to Federal Decree-Law No. 41 of 2024 (Art. 87) on Genetic Health Data, CDS Law 2026 provisions regarding Minors' health information, and UAE PDPL (Personal Data Protection Law). Genetic counselling is mandatory prior to testing.
Facility Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 9834453.
Contact: +971 54 548 8731 (WhatsApp & Phone) | 24/7 Home Collection: 8 AM - 11 PM
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians